MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.3B
This Quarter Return
+29.05%
1 Year Return
+46.22%
3 Year Return
+108.24%
5 Year Return
–
10 Year Return
–
AUM
$15.1B
AUM Growth
+$15.1B
(+15%)
Cap. Flow
-$879M
Cap. Flow
% of AUM
-5.81%
Top 10 Holdings %
Top 10 Hldgs %
19.25%
Holding
1,647
New
467
Increased
323
Reduced
312
Closed
527
Top Buys
| 1 |
JPMorgan Chase
JPM
|
$147M |
| 2 |
Humana
HUM
|
$113M |
| 3 |
Meta Platforms (Facebook)
META
|
$111M |
| 4 |
Lowe's Companies
LOW
|
$97.1M |
| 5 |
Motorola Solutions
MSI
|
$88.4M |
Top Sells
| 1 |
Merck
MRK
|
$204M |
| 2 |
Johnson & Johnson
JNJ
|
$183M |
| 3 |
NVIDIA
NVDA
|
$180M |
| 4 |
Adobe
ADBE
|
$158M |
| 5 |
Pfizer
PFE
|
$151M |
Sector Composition
| 1 | Healthcare | 27.79% |
| 2 | Technology | 18.34% |
| 3 | Consumer Discretionary | 12.93% |
| 4 | Financials | 8.18% |
| 5 | Industrials | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHX
101
DELISTED
ChampionX
CHX
| $39.1M | 0.26% |
4,001,605
+3,926,071
| +5,198% | +$38.3M |
|
102
TSMC
TSM
$1.2T
| $39M | 0.26% |
686,593
+574,350
| +512% | +$32.6M |
|
103
United Therapeutics
UTHR
$17.7B
| $38.5M | 0.25% |
318,336
+287,192
| +922% | +$34.8M |
|
104
Canadian Natural Resources
CNQ
$65B
| $38.2M | 0.25% |
+2,208,438
| New | +$38.2M |
|
105
Cigna
CI
$80.2B
| $38M | 0.25% |
202,714
-135,225
| -40% | -$25.4M |
|
|
WRK
106
DELISTED
WestRock Company
WRK
| $37M | 0.24% |
1,309,732
+1,176,159
| +881% | +$33.2M |
|
|
XEC
107
DELISTED
CIMAREX ENERGY CO
XEC
| $35.6M | 0.24% |
1,294,643
+1,277,745
| +7,562% | +$35.1M |
|
108
Analog Devices
ADI
$120B
| $35.6M | 0.24% |
290,149
-121,357
| -29% | -$14.9M |
|
109
MPLX
MPLX
$51.9B
| $35.4M | 0.23% |
2,050,897
+1,675,680
| +447% | +$29M |
|
110
Ecolab
ECL
$77.5B
| $35M | 0.23% |
175,751
+34,065
| +24% | +$6.78M |
|
111
Tyson Foods
TSN
$20B
| $34.4M | 0.23% |
576,040
+540,247
| +1,509% | +$32.3M |
|
112
CVS Health
CVS
$93B
| $34.1M | 0.23% |
525,080
-823,410
| -61% | -$53.5M |
|
113
Regeneron Pharmaceuticals
REGN
$59.8B
| $34M | 0.22% |
54,475
+43,413
| +392% | +$27.1M |
|
|
GBT
114
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $33.8M | 0.22% |
535,276
+450,108
| +528% | +$28.4M |
|
115
Lam Research
LRCX
$124B
| $33.7M | 0.22% |
104,076
-151,787
| -59% | -$49.1M |
|
|
WWE
116
DELISTED
World Wrestling Entertainment
WWE
| $33.5M | 0.22% |
770,025
-284,002
| -27% | -$12.3M |
|
|
MYOK
117
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $33.2M | 0.22% |
343,783
+39,188
| +13% | +$3.79M |
|
118
NVR
NVR
$22.6B
| $32.7M | 0.22% |
10,031
-4,178
| -29% | -$13.6M |
|
119
Sherwin-Williams
SHW
$90.5B
| $32.5M | 0.21% |
56,253
-8,453
| -13% | -$4.88M |
|
|
PE
120
DELISTED
PARSLEY ENERGY INC
PE
| $32.4M | 0.21% |
+3,030,863
| New | +$32.4M |
|
121
PTC
PTC
$25.4B
| $32.3M | 0.21% |
415,582
-587,624
| -59% | -$45.7M |
|
122
Carlisle Companies
CSL
$16B
| $32.1M | 0.21% |
+267,879
| New | +$32.1M |
|
|
123
Johnson & Johnson
JNJ
$429B
| $32M | 0.21% |
227,246
-1,300,748
| -85% | -$183M |
|
124
Liberty Media Series C
FWONK
$25B
| $31.5M | 0.21% |
991,933
+985,169
| +14,565% | +$31.2M |
|
125
DuPont de Nemours
DD
$31.6B
| $30.8M | 0.2% |
579,034
-755,861
| -57% | -$40.2M |
|